January 13th 2021
AstraZeneca’s leading diabetes medication could be approved to treat chronic kidney disease for patients with and without type 2 diabetes.
January 12th 2021
New treatment for metastatic HER2-positive breast cancer is called Margenza.
January 6th 2021
Many pharmaceutical manufacturers are raising prices this year, but at a lower overall rate than in the past couple of years, according to a new analysis.
January 4th 2021
Amphastar Pharmaceuticals’ generic version will offer stiff competition to Eli Lilly’s Glucagon Emergency Kit for Low Blood Sugar.
December 22nd 2020
The biosimilar to Rituxan is expected to erode market share of the mainstay cancer drug for Roche.